China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) SHH

Currency In CNY

AD

Valuation

Market Cap18.89B
Enterprise Value18.13B
P/E Ratio10.68
PEG Ratio480.77T
Price/Sales Ratio1.62
Price/Book Ratio1.44
Enterprise/Revenue1.54
Enterprise/EBITDA6.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.15
Operating Margin0.16
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.14

Income Statement

Revenue11B
Revenue/Share10.33
Gross Profit6.38B
EBITDA2.73B
Net Income1.65B
Diluted EPS1.59

Balance Sheet

Total Cash3.07B
Total Cash/Share2.96
Total Debt1.7B
Total Debt/Equity0.14
Current Ratio2.67
Book Value Per Share12.52

Price History

52-Week Change-10.61
52-Week High22.14
52-Week Low15.29
Moving Average 50 Days16.99
Moving Average 200 Days18.2

Statistics

Average Volume7.01M
Shares Outstanding1.04B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.47
Trailing Annual Dividend Yield2.81
Payout Ratio0.04
Last Split Factor6:5
Last Split DateAugust 16, 2018
AD